128 related articles for article (PubMed ID: 7861183)
21. Morphology and distribution of eosinophilic granulocytes in damselfish neurofibromatosis, a model of mast cell distribution in neurofibromatosis type 1.
Vicha DL; Schmale MC
Anticancer Res; 1994; 14(3A):947-52. PubMed ID: 8074497
[TBL] [Abstract][Full Text] [Related]
22. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
23. Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells.
Sobue G; Sonnenfeld K; Rubenstein AE; Pleasure D
Ann Neurol; 1985 Jul; 18(1):68-73. PubMed ID: 2994552
[TBL] [Abstract][Full Text] [Related]
24. Differences in a K current in Schwann cells from normal and neurofibromatosis-infected damselfish.
Fieber LA; Schmale MC
Glia; 1994 May; 11(1):64-72. PubMed ID: 8070896
[TBL] [Abstract][Full Text] [Related]
25. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.
Peltonen J; Jaakkola S; Lebwohl M; Renvall S; Risteli L; Virtanen I; Uitto J
Lab Invest; 1988 Dec; 59(6):760-71. PubMed ID: 2462129
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas.
Johnson MD; Glick AD; Davis BW
Arch Pathol Lab Med; 1988 Feb; 112(2):155-60. PubMed ID: 2447857
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromas in NF1: Schwann cell origin and role of tumor environment.
Zhu Y; Ghosh P; Charnay P; Burns DK; Parada LF
Science; 2002 May; 296(5569):920-2. PubMed ID: 11988578
[TBL] [Abstract][Full Text] [Related]
28. Glu-tubulin is a marker for Schwann cells and can distinguish between schwannomas and neurofibromas.
García-Sanmartín J; Rubio-Mediavilla S; Sola-Gallego JJ; Martínez A
Histochem Cell Biol; 2016 Oct; 146(4):467-77. PubMed ID: 27278446
[TBL] [Abstract][Full Text] [Related]
29. Human peripheral nerve sheath neoplasm: expression of Schwann cell-related markers and their relation to malignant transformation.
Yasuda T; Sobue G; Ito T; Doyu M; Sugiura I; Hashizume Y; Kato K
Muscle Nerve; 1991 Sep; 14(9):812-9. PubMed ID: 1656253
[TBL] [Abstract][Full Text] [Related]
30. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
31. Benign neural tumors of the oral cavity: a comparative immunohistochemical study.
Chrysomali E; Papanicolaou SI; Dekker NP; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):381-90. PubMed ID: 9347502
[TBL] [Abstract][Full Text] [Related]
32. Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.
Rosenbaum T; Boissy YL; Kombrinck K; Brannan CI; Jenkins NA; Copeland NG; Ratner N
Development; 1995 Nov; 121(11):3583-92. PubMed ID: 8582272
[TBL] [Abstract][Full Text] [Related]
33. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene.
Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H
Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454
[TBL] [Abstract][Full Text] [Related]
34. Neurofibroma and schwannoma.
Ferner RE; O'Doherty MJ
Curr Opin Neurol; 2002 Dec; 15(6):679-84. PubMed ID: 12447105
[TBL] [Abstract][Full Text] [Related]
35. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
[TBL] [Abstract][Full Text] [Related]
36. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors.
Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
Hum Pathol; 1989 Nov; 20(11):1089-96. PubMed ID: 2478442
[TBL] [Abstract][Full Text] [Related]
37. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms.
Gray MH; Smoller BR; McNutt NS; Hsu A
Am J Dermatopathol; 1990 Jun; 12(3):234-41. PubMed ID: 1693815
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic induction of the Ink4a/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge.
Gomez-Sanchez JA; Gomis-Coloma C; Morenilla-Palao C; Peiro G; Serra E; Serrano M; Cabedo H
Brain; 2013 Jul; 136(Pt 7):2262-78. PubMed ID: 23748155
[TBL] [Abstract][Full Text] [Related]
40. Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 schwannomas and 18 neurofibromas.
Kawahara E; Oda Y; Ooi A; Katsuda S; Nakanishi I; Umeda S
Am J Surg Pathol; 1988 Feb; 12(2):115-20. PubMed ID: 3124642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
